Validity of current somatoform disorder diagnoses: Perspectives for classification in DSM-V and ICD-11

Psychopathology

Volumn 41, Issue 1, 2007, Pages 4-9

  Löwe, Bernd ^a   Mundt, Christoph ^a   Herzog, Wolfgang ^a   Brunner, Romuald ^a   Backenstrass, Matthias ^a   Kronmüller, Klaus ^a   Henningsen, Peter ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diagnostic and Statistical Manual of Mental Disorders, classification; International Classification of Diseases; Literature review; Reproducibility of results; Somatoform disorders, diagnosis, validity

Indexed keywords

CLINICAL FEATURE; CONTENT VALIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INFORMATION RETRIEVAL; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL INFORMATION; MEDLINE; PREDICTION; PSYCINFO; REVIEW; SOMATOFORM DISORDER;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SOMATOFORM DISORDERS;

EID: 36349013787     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109949     Document Type: Review

References (58)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, rev (DSM-IV-TR). Washington, American Psychiatric Association, 2000.
2. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organization, 1992.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 (DSM-III). Washington, American Psychiatric Association, 1980.
4. Kroenke K, Spitzer RL, deGruy FV 3rd, Hahn SR, Linzer M, Williams JB, Brody D, Davies M: Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 1997;54:352-358.
5. Escobar JI, Manu P, Matthews D, Lane T, Swartz M, Canino G: Medically unexplained physical symptoms, somatization disorder and abridged somatization: studies with the Diagnostic Interview Schedule. Psychiatr Dev 1989;7:235-245.
6. Rief W, Hiller W: Toward empirically based criteria for the classification of somatoform disorders. J Psychosom Res 1999;46:507-518.
7. Barsky AJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62:903-910.
8. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M: Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005;162:847-855.
9. Sykes R: Somatoform disorders in DSM-IV: mental or physical disorders? J Psychosom Res 2006;60:341-344.
10. Fink P, Rosendal M, Olesen F: Classification of somatization and functional somatic symptoms in primary care. Aust NZ J Psychiatry 2005;39:772-781.
11. Henningsen P, Zimmermann T, Sattel H: Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003;65:528-533.
12. Levenson JL: A rose by any other name is still a rose. J Psychosom Res 2006;60:325-326.
13. Hiller W: Don't change a winning horse. J Psychosom Res 2006;60:345-347.
14. Hiller W, Rief W: Why DSM-III was right to introduce the concept of somatoform disorders. Psychosomatics 2005;46:105-108.
15. Rosendal M, Fink P, Bro F, Olesen F: Somatization, heartsink patients, or functional somatic symptoms? Towards a clinical useful classification in primary health care. Scand J Prim Health Care 2005;23:3-10.
16. Rief W, Henningsen P, Hiller W: Classification of somatoform disorders. Am J Psychiatry 2006;163:746-747.
17. Sharpe M, Mayou R: Somatoform disorders: a help or hindrance to good patient care? Br J Psychiatry 2004;184:465-467.
18. Creed F, Barsky A: A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004;56:391-408.
19. Rief W, Nanke A, Emmerich J, Bender A, Zech T: Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. J Psychosom Res 2004;57:367-371.
20. De Waal MW, Arnold IA, Eekhof JA, Van Hemert AM: Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004;184:470-476.
21. Starcevic V: Somatoform disorders in DSM-V: conceptual and political issues in the debate. Psychosomatics 2006;47:277-281.
22. Cronbach LJ, Meehl PE: Construct validity in psychological tests. Psychol Bull 1955;52:281-302.
23. Fletcher RH, Fletcher SW, Wagner EH: Clinical Epidemiology. The Essentials, ed 3. Philadelphia, Lippincott, 1996.
24. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB: Designing Clinical Research. An Epidemiologic Approach, ed 2. Philadelphia, Lippincott, 2001.
25. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV, Brody D, Davies M: Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 Study. JAMA 1995;274:1511-1517.
26. Thomassen R, Van Hemert AM, Huyse FJ, van der Mast RC, Hengeveld MW: Somatoform disorders in consultation-liaison psychiatry: a comparison with other mental disorders. Gen Hosp Psychiatry 2003;25:8-13.
27. Smith GR Jr, Monson RA, Ray DC: Patients with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Arch Intern Med 1986;146:69-72.
28. Fink P: The use of hospitalizations by persistent somatizing patients. Psychol Med 1992;22:173-180.
29. Kendell R, Jablensky A: Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003;160:4-12.
30. Jablensky A: Categories, dimensions and prototypes: critical issues for psychiatric classification. Psychopathology 2005;38:201-205.
31. Widiger TA: A dimensional model of psychopathology. Psychopathology 2005;38:211-214.
32. Henningsen P, Zipfel S, Herzog W: Management of functional somatic syndromes: approaches and evidence. Lancet, in press.
33. Aaron LA, Buchwald D: A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001;134:868-881.
34. Wessely S, Nimnuan C, Sharpe M: Functional somatic syndromes: one or many? Lancet 1999;354:936-939.
35. Henningsen P, Jakobsen T, Schiltenwolf M, Weiss MG: Somatization revisited: diagnosis and perceived causes of common mental disorders. J Nerv Ment Dis 2005;193:85-92.
36. De Gucht V, Maes S: Explaining medically unexplained symptoms: toward a multidimensional, theory-based approach to somatization. J Psychosom Res 2006;60:349-352.
37. Creed F: Can DSM-V facilitate productive research into the somatoform disorders? J Psychosom Res 2006;60:331-334.
38. Rief W, Sharpe M: Somatoform disorders - new approaches to classification, conceptualization, and treatment. J Psychosom Res 2004;56:387-390.
39. Janet P: L' automatisme psychologique. Essay de la psycholgie expérimentale sur les formes inférieures de l'activité humaine. Paris, Félix Alcan, 1889.
40. Freud S, Breuer J: Studien über Hysterie (originally published: 1895). Frankfurt, Fischer; 1979.
41. Schur M: Comments on the metapsychology of somatization. Psychoanal Study Child 1955;10:119-164.
42. Lipowski ZJ: Somatization: the concept and its clinical application. Am J Psychiatry 1988;145:1358-1368.
43. Lipowski ZJ: Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom 1987;47:160-167.
44. Brown RJ: Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull 2004;130:793-812.
45. De Gucht V, Fischler B: Somatization: a critical review of conceptual and methodological issues. Psychosomatics 2002;43:1-9.
46. Rief W, Barsky AJ: Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005;30:996-1002.
47. Kirmayer LJ, Taillefer S: Somatoform disorders; in Turner SM, Hersen M (eds): Adult Psychopathology and Diagnosis, ed 3. New York, Wiley, 1997, pp 333-383.
48. Wise TN, Birket-Smith M: The somatoform disorders for DSM-V: the need for changes in process and content. Psychosomatics 2002;43:437-440.
49. Mayou R, Levenson J, Sharpe M: Somatoform disorders in DSM-V. Psychosomatics 2003;44:449-451.
50. Janca A: Rethinking somatoform disorders. Curr Opin Psychiatry 2005;18:65-71.
51. Kroenke K: Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 2006;60:335-339.
52. Sharpe M, Mayou R, Walker J: Bodily symptoms: new approaches to classification. J Psychosom Res 2006;60:353-356.
53. Gureje O, Simon GE: The natural history of somatization in primary care. Psychol Med 1999;29:669-676.
54. Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205-215.
55. Hiller W, Fichter MM, Rief W: A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res 2003;54:369-380.
56. Fallon BA: Pharmacotherapy of somatoform disorders. J Psychosom Res 2004;56:455-460.
57. Greco T, Eckert G, Kroenke K: The outcome of physical symptoms with treatment of depression. J Gen Intern Med 2004;19:813-818.
58. Müller T, Mannel M, Murck H, Rahlfs VW: Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. Psychosom Med 2004;66:538-547.